Clinical Trials: Influenza

Alabama

Birmingham; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Birmingham; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Arkansas

Little Rock; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

California

Los Angeles; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

San Francisco; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Colorado

Denver; Radiant Research - Denver
Flu Vaccine Research Study

Denver; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Denver; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Delaware

Newark; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Newark; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Florida

Clearwater; Tampa Bay Medical Research, Inc
Pneumonia Vaccine/Flu Vaccine Research Study

Gainesville; Florida Medical Research Institute
Do You Have The FLU?

Oviedo; Biomedical Research Alliance of New York
Acute Influenza- Adults

St Petersburg; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

West Palm Beach; Research Site:
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Georgia

Atlanta; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Atlanta; Clinical Research Atlanta
Got a COLD or the FLU?

Augusta; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Stockbridge; Clinical Research Atlanta (Stockbridge)
Got a COLD or the FLU?

Illinois

Chicago; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Chicago; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Louisiana

New Orleans; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Massachusetts

Boston; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Springfield; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Michigan

Detroit; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Detroit; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Minnesota

Brooklyn Center; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Missouri

St. Louis; Radiant Research - St. Louis
Pneumonia and Flu Vaccine Study

Montana

Missoula; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

New Jersey

Camden; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Hackensack; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Hackensack; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

New York

New York; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Wantagh; Biomedical Research Alliance of New York
Acute Influenza- Adults

North Carolina

Winston-Salem; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

North Dakota

Bismarck; Odyssey Research Services
A ParaInfluenza Virus Type III Vaccine Study

Bismarck; Odyssey Research Services
An Influenza Research Study

Ohio

Cincinnati; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Cincinnati; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Cleveland; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Cleveland; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Dayton; Providence Health Partners - Center for Clinical Research
Influenza

Oklahoma

Oklahoma City; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Oregon

Portland; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Pennsylvania

Hershey; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Philadelphia; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Philadelphia; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Pittsburgh; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Pittsburgh; Research Site:
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Tennessee

Jackson; Research Site:
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Texas

Dallas; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Dallas; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Dallas; Radiant Research - Dallas North
Cold or Flu Research Study

El Paso; Research Site:
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Houston; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Houston; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Lubbock; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

San Antonio; Radiant Research - San Antonio
Need A Flu Vaccine?

San Antonio; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

San Antonio; Radiant Research - San Antonio
Flu Vaccine Research

Temple; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Utah

Salt Lake City; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

International

Aalst, Belgium; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Aalst, Belgium; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Bruxelles, Belgium; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Bruxelles, Belgium; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Edegem, Belgium; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Leuven, Belgium; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Leuven, Belgium; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Plovdiv, Bulgaria; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Sofia, Bulgaria; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Coquitlam, BC, Canada; Research Site:
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Saskatoon, SK, Canada; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Winnipeg, MB, Canada; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Brno, Czech Republic; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Plzen, Czech Republic; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Praha, Czech Republic; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Aalborg, Denmark; Research Site:
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Tallinn, Estonia; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Tallinn, Estonia; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Tartu, Estonia; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Tartu, Estonia; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Paris, France; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Paris, France; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Toulouse, France; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Toulouse, France; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Tours, France; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Tours, France; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Aachen, Germany; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Aachen, Germany; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Berlin, Germany; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Essen, Germany; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Hamburg, Germany; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Heidelberg, Germany; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Heidelberg, Germany; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

München, Germany; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

München, Germany; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Athens, Greece; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Budapest, Hungary; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Budapest, Hungary; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Pecs, Hungary; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Pecs, Hungary; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Szeged, Hungary; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Szeged, Hungary; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Haifa, Israel; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Jerusalem, Israel; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Jerusalem, Israel; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Petah Tikva, Israel; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Petah Tikva, Israel; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Ramat Gan, Israel; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Ramat Gan, Israel; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Tel Aviv, Israel; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Padova, Italy; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Pavia, Italy; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Pavia, Italy; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Roma, Italy; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Kaunas, Lithuania; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Kaunas, Lithuania; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Vilnius, Lithuania; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Vilnius, Lithuania; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Bialystok, Poland; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Lodz, Poland; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Szczecin, Poland; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Warszawa, Poland; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Wroclaw, Poland; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Bucharest, Romania; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Barcelona, Spain; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Madrid, Spain; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Madrid, Spain; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Zürich, Switzerland; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Kiev, Ukraine; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Lugnansk, Ukraine; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Zaporozhye, Ukraine; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Birmingham, United Kingdom; Research Site:
A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Nottingham, United Kingdom; Research Site:
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.